Britain’s Clinigen Group has agreed to be bought by UK-based private-equity firm Triton Investment Management in a deal that values the pharmaceutical services firm at about $1.6bn, the companies said on Wednesday.
Last week, Clinigen had confirmed advanced talks with Triton over a possible deal as pressure built up on the company on reports of activist investor Elliott Management raising its stake to propose a break up of Clinigen.
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
Triton has offered 883 pence per share in cash, with shareholders also eligible to receive a previously declared final dividend of 5.46 pence per Clinigen Share, the companies said.
London-listed Clinigen helps drug developers manage clinical supplies and provides real-world data about medicines, and would be the latest addition to Triton’s burgeoning healthcare portfolio.
Source: Reuters
Can’t stop reading? Read more
Apollo, CVC, Ares, and Sixth Street circle Serie A media rights stake
Apollo, CVC, Ares, and Sixth Street circle Serie A media rights stake Private equity firms...
Neuberger Berman leads continuation vehicle for Tailwind’s Axis Portable Air
Neuberger Berman leads continuation vehicle for Tailwind’s Axis Portable Air Neuberger has...
Chicago Atlantic expands into emerging markets private credit amid US investor pullback
Chicago Atlantic expands into emerging markets private credit amid US investor pullback Chicago...